Hershman, Dawn L <br/><br/>
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jul 2013 
 - 2627-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2012.44.8738  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcarnitine--administration & dosage<br/>Adult<br/>Aged<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Dietary Supplements<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Linear Models<br/>Mastectomy--methods<br/>Middle Aged<br/>Multivariate Analysis<br/>Nerve Regeneration--drug effects<br/>Peripheral Nervous System Diseases--chemically induced<br/>Reference Values<br/>Risk Assessment<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>Taxoids--adverse effects<br/>Treatment Outcome